TipRanks
BeOne Medicines (DE:49BA)
FRANKFURT:49BA

Compare BeOne Medicines (49BA) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
BeOne Medicines
€318.00
€37.01B
26.33
10.34%
14 Buy
0 Hold
0 Sell
Strong Buy
Exelixis
$56.72
$14.45B
17.76
47.46%
3 Buy
9 Hold
1 Sell
Hold
Incyte
$128.12
$22.85B
13.95
30.14%
11 Buy
10 Hold
0 Sell
Moderate Buy
Summit Therapeutics
$14.23
$13.81B
-16.03
-19.47%
10 Buy
6 Hold
0 Sell
Moderate Buy
Zai Lab
$26.82
$3.01B
-14.54
-23.05%
3 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$34.36
$22.25B
29.11
12.29%
9 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:49BA
BeOne Medicines
320.00
36.00
12.68%
EXEL
Exelixis
58.44
19.87
51.52%
INCY
Incyte
113.44
28.69
33.85%
SMMT
Summit Therapeutics
17.95
-4.70
-20.75%
ZLAB
Zai Lab
25.31
-7.39
-22.60%
GMAB
Genmab
36.65
4.80
15.07%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts